Americans With Rare Barth Syndrome Losing Hope in FDA
August 23, 2025
24,987
434
86
2.08%
Search the Record
IndexedEvery word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Inside Edition Episodes Around August 23, 2025
See what was published immediately before and after this episode.
9:40Now PlayingAmericans With Rare Barth Syndrome Losing Hope in FDA
YouTube Description
as posted by the channelBarth Syndrome is a genetic disease so rare that fewer than 200 Americans have it, and there are under 300 known cases worldwide. It hinders the mitochondria in cells and primarily impairs the heart's functionality. Americans with the illness were given a ray of hope in recent years thanks to an experimental drug called Elamipretide. The FDA recently refused a request to reconsider a drug application from its makers, prolonging the federal approval process.
Guests & Subjects Covered
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.